


<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2025-09-09T14:04:03Z</responseDate>
    <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:12405973" metadataPrefix="pmc">https://pmc.ncbi.nlm.nih.gov/api/oai/v1/mh/</request>
    
    <GetRecord>
        <record>
    <header>
    <identifier>oai:pubmedcentral.nih.gov:12405973</identifier>
    <datestamp>2025-09-04</datestamp>
    
        
        <setSpec>pmc-open</setSpec>
        
    
</header>
    <metadata>
        
        <article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.4/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.4/ https://jats.nlm.nih.gov/archiving/1.4/xsd/JATS-archivearticle1-4.xsd" id="eji70047" xml:lang="en" article-type="other" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur J Immunol</journal-id><journal-id journal-id-type="iso-abbrev">Eur J Immunol</journal-id><journal-id journal-id-type="pmc-domain-id">379</journal-id><journal-id journal-id-type="pmc-domain">blackwellopen</journal-id><journal-id journal-id-type="publisher-id">EJI</journal-id><journal-title-group><journal-title>European Journal of Immunology</journal-title></journal-title-group><issn pub-type="ppub">0014-2980</issn><issn pub-type="epub">1521-4141</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Wiley Open Access Collection</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12405973</article-id><article-id pub-id-type="pmcid-ver">PMC12405973.1</article-id><article-id pub-id-type="pmcaid">12405973</article-id><article-id pub-id-type="pmcaiid">12405973</article-id><article-id pub-id-type="pmid">40899100</article-id><article-id pub-id-type="doi">10.1002/eji.70047</article-id><article-id pub-id-type="publisher-id">EJI70047</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="overline"><subject>Notes and Insights</subject></subj-group><subj-group subj-group-type="heading"><subject>Notes and Insights</subject></subj-group></article-categories><title-group><article-title>Baseline Single&#8208;Cell Differences in Polyfunctionality Between Systemic Autoinflammatory Diseases Patients and Healthy Controls</article-title></title-group><contrib-group><contrib id="eji70047-cr-0001" contrib-type="author"><name name-style="western"><surname>Linder</surname><given-names initials="A">Aline</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0008-0965-1949</contrib-id><xref rid="eji70047-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="eji70047-cr-0002" contrib-type="author"><name name-style="western"><surname>Diab</surname><given-names initials="F">Farah</given-names></name><xref rid="eji70047-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="eji70047-cr-0003" contrib-type="author"><name name-style="western"><surname>de Pontual</surname><given-names initials="L">Lo&#239;c</given-names></name><xref rid="eji70047-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="eji70047-cr-0004" contrib-type="author"><name name-style="western"><surname>Giurgea</surname><given-names initials="I">Irina</given-names></name><xref rid="eji70047-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="eji70047-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib id="eji70047-cr-0005" contrib-type="author" corresp="yes"><name name-style="western"><surname>Eyer</surname><given-names initials="K">Klaus</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-9344-5110</contrib-id><xref rid="eji70047-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="eji70047-aff-0005" ref-type="aff">
<sup>5</sup>
</xref><address><email>eyerk@biomed.au.dk</email></address></contrib></contrib-group><aff id="eji70047-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Laboratory For Functional Immune Repertoire Analysis, Department of Chemistry and Applied Biosciences</named-content>
<institution>ETH Zurich</institution>
<city>Zurich</city>
<country country="CH">Switzerland</country>
</aff><aff id="eji70047-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Sorbonne Universit&#233;, Inserm</named-content>
<institution>Maladies g&#233;n&#233;tiques d'expression p&#233;diatrique</institution>
<city>Paris</city>
<country country="FR">France</country>
</aff><aff id="eji70047-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">Service de P&#233;diatrie</named-content>
<institution>H&#244;pital Jean Verdier</institution>
<city>Bondy</city>
<country country="FR">France</country>
</aff><aff id="eji70047-aff-0004">
<label>
<sup>4</sup>
</label>
<named-content content-type="organisation-division">Sorbonne Universit&#233;, APHP</named-content>
<institution>H&#244;pital Armand&#8208;Trousseau</institution>
<city>Paris</city>
<country country="FR">France</country>
</aff><aff id="eji70047-aff-0005">
<label>
<sup>5</sup>
</label>
<named-content content-type="organisation-division">Department of Biomedicine</named-content>
<institution>Aarhus University</institution>
<city>Aarhus</city>
<country country="DK">Denmark</country>
</aff><pub-date pub-type="epub"><day>03</day><month>9</month><year>2025</year></pub-date><pub-date pub-type="ppub"><month>9</month><year>2025</year></pub-date><volume>55</volume><issue seq="70">9</issue><issue-id pub-id-type="pmc-issue-id">496084</issue-id><issue-id pub-id-type="doi">10.1002/eji.v55.9</issue-id><elocation-id>e70047</elocation-id><history><date date-type="rev-recd"><day>18</day><month>8</month><year>2025</year></date><date date-type="received"><day>12</day><month>5</month><year>2025</year></date><date date-type="accepted"><day>19</day><month>8</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>03</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>04</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-04 00:25:59.930"><day>04</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement content-type="article-copyright">&#169; 2025 The Author(s). <italic toggle="yes">European Journal of Immunology</italic> published by Wiley&#8208;VCH GmbH</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pmc-pdf" xlink:href="EJI-55-e70047.pdf"/><self-uri content-type="pdf" xlink:href="file:EJI-55-e70047.pdf"/><abstract id="eji70047-abs-0001" abstract-type="graphical"><p>Dysregulated cytokine secretion and signaling underlie systemic autoinflammatory diseases (SAIDs). Here, we characterized immune dysregulation in SAID patients by profiling cytokine secretion at the single&#8208;cell level, establishing measurements for secretion dynamics and cellular polyfunctionality, compared with healthy controls, revealing natural variability within immune responses between donors.
<boxed-text position="anchor" content-type="graphic" orientation="portrait"><graphic position="anchor" id="jats-graphic-1" orientation="portrait" xlink:href="EJI-55-e70047-g001.jpg"/></boxed-text>
</p></abstract><funding-group><award-group id="funding-0001"><funding-source><institution-wrap><institution>Personalized Health and Related Technologies (PHRT)</institution></institution-wrap></funding-source><award-id>2021&#8208;349</award-id></award-group></funding-group><counts><fig-count count="3"/><table-count count="0"/><page-count count="4"/><word-count count="1815"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>September 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.6.2 mode:remove_FC converted:03.09.2025</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="eji70047-cit-0001"><string-name name-style="western"><given-names>A.</given-names><surname>Linder</surname></string-name>, <string-name name-style="western"><given-names>F.</given-names><surname>Diab</surname></string-name>, <string-name name-style="western"><given-names>L.</given-names><surname>de Pontual</surname></string-name>, <string-name name-style="western"><given-names>I.</given-names><surname>Giurgea</surname></string-name>, and <string-name name-style="western"><given-names>K.</given-names><surname>Eyer</surname></string-name>, &#8220;<article-title>Baseline Single&#8208;Cell Differences in Polyfunctionality Between Systemic Autoinflammatory Diseases Patients and Healthy Controls</article-title>.&#8221; <source>European Journal of Immunology</source><volume>55</volume>, no. <issue>9</issue> (<year>2025</year>): <volume>55</volume>, <elocation-id>e70047</elocation-id>. <pub-id pub-id-type="doi">10.1002/eji.70047</pub-id><pub-id pub-id-type="pmid">40899100</pub-id><pub-id pub-id-type="pmcid">PMC12405973</pub-id></mixed-citation>
</p><fn-group><fn id="eji70047-note-0001"><p>
<bold>Funding</bold>: The study received support from Personalized Health and Related Technologies (PHRT): 2021&#8208;349.</p></fn></fn-group></notes></front><body><p>If not properly regulated, activation of inflammatory pathways can cause immune&#8208;mediated disorders such as systemic autoinflammatory diseases (SAIDs) [<xref rid="eji70047-bib-0001" ref-type="bibr">1</xref>, <xref rid="eji70047-bib-0002" ref-type="bibr">2</xref>]. SAIDs are rare, heterogeneous conditions that include both monogenic and multifactorial forms [<xref rid="eji70047-bib-0001" ref-type="bibr">1</xref>, <xref rid="eji70047-bib-0002" ref-type="bibr">2</xref>]. They typically are due to mutations in components of the innate immune system [<xref rid="eji70047-bib-0003" ref-type="bibr">3</xref>], leading to recurrent inflammatory episodes [<xref rid="eji70047-bib-0004" ref-type="bibr">4</xref>]. A well&#8208;described example of SAID is tumor necrosis factor receptor&#8208;associated periodic syndrome (TRAPS) [<xref rid="eji70047-bib-0005" ref-type="bibr">5</xref>]. However, defects in various other pathways can also underlie SAIDs, complicating both the diagnosis and treatment [<xref rid="eji70047-bib-0001" ref-type="bibr">1</xref>, <xref rid="eji70047-bib-0002" ref-type="bibr">2</xref>], as disease&#8208;causing mutations are usually found in only 40%&#8211;60% of cases [<xref rid="eji70047-bib-0004" ref-type="bibr">4</xref>, <xref rid="eji70047-bib-0006" ref-type="bibr">6</xref>]. Rather than relying on often&#8208;normal plasma levels during active disease [<xref rid="eji70047-bib-0007" ref-type="bibr">7</xref>], we utilized a single&#8208;cell functional analysis platform capable of quantifying cytokine secretion from individual immune cells [<xref rid="eji70047-bib-0008" ref-type="bibr">8</xref>, <xref rid="eji70047-bib-0009" ref-type="bibr">9</xref>]. This method captures cytokine signatures in detail and reveals differences in polyfunctionality (Figure&#160;<xref rid="eji70047-fig-0001" ref-type="fig">1</xref>) [<xref rid="eji70047-bib-0010" ref-type="bibr">10</xref>], offering high&#8208;resolution insights into immune dysregulation (<xref rid="eji70047-supinfo-0001" ref-type="">Methods, Figure S1</xref>).</p><fig position="float" fig-type="FIGURE" id="eji70047-fig-0001" orientation="portrait"><label>FIGURE 1</label><caption><p>(A) Overview of the workflow. (B) A sandwich immunoassay using magnetic capture beads and fluorescent detection antibodies quantified IL&#8208;6, TNF&#8208;&#945;, and IL&#8208;1&#946; secretion from individual cells. Fluorescence relocation indicated secretion, as shown in the micrograph for a cell secreting all three cytokines. Created with BioRender.com, scale bar: 25&#160;&#181;m. (C) Frequencies of cells secreting IL&#8208;6, TNF&#8208;&#945;, and IL&#8208;1&#946; after 6&#160;h LPS stimulation or unstimulated, and (D), the same data resolved for polyfunctionality. From left to right: co&#8208;secretion with IL&#8208;6 as a base, followed by TNF&#8208;&#945; and IL&#8208;1&#946;. Data shown as mean &#177;SD for healthy controls (<italic toggle="yes">N&#160;</italic>=&#160;10) and mean &#177;SEM for patient replicates (TRAPS<sub>Treated</sub>
<italic toggle="yes">N&#160;</italic>=&#160;1/<italic toggle="yes">n&#160;</italic>=&#160;3; TRAPS<sub>Untreated</sub>
<italic toggle="yes">N&#160;</italic>=&#160;1/<italic toggle="yes">n&#160;</italic>=&#160;2; SAID<sub>Undefined</sub>
<italic toggle="yes">N&#160;</italic>=&#160;1/<italic toggle="yes">n&#160;</italic>=&#160;1). One&#8208;way ANOVA with Tukey's post hoc test; *<italic toggle="yes">p&#160;</italic>&lt;&#160;0.05, **<italic toggle="yes">p&#160;</italic>&lt;&#160;0.01.</p></caption><graphic position="anchor" id="jats-graphic-3" orientation="portrait" xlink:href="EJI-55-e70047-g002.jpg"/></fig><p>We first assessed the frequency of cytokine&#8208;secreting cells (SCs) producing IL&#8208;6, TNF&#8208;&#945;, and IL&#8208;1&#946; in healthy controls and SAIDs patients. Looking at the basal immune response after 6 h incubation (healthy donors, <italic toggle="yes">n</italic>&#160;=&#160;10, without stimulation), we found 0.33&#160;&#177;&#160;0.28% IL&#8208;6&#8208;SCs, 0.32&#160;&#177;&#160;0.15% TNF&#8208;&#945;&#8208;SCs, and 0.11&#160;&#177;&#160;0.03% IL&#8208;1&#946;&#8208;SCs (Figure&#160;<xref rid="eji70047-fig-0001" ref-type="fig">1C</xref>). Upon stimulation with LPS, the healthy control group displayed a 5&#8208;to&#8208;16&#8208;fold increase. A large variation in the frequencies of SCs was notable within the healthy individuals, highlighting a large variability in the proportion of activated cells in healthy individuals in response to LPS.</p><p>Our small exploration cohort comprised SAIDs patients, including two individuals diagnosed with TRAPS and a patient with undefined SAID (Table <xref rid="eji70047-supinfo-0001" ref-type="">S1</xref>; Figure&#160;<xref rid="eji70047-fig-0001" ref-type="fig">1C</xref>). Regarding both TRAPS samples, they displayed similar frequencies to healthy controls of SCs after stimulation with LPS for 6&#160;h (IL&#8208;6&#8208;SCs 1.44&#160;&#177;&#160;0.19% and 1.19&#160;&#177;&#160;0.23%, TNF&#8208;&#945; 1.10&#160;&#177;&#160;0.19% and 0.81&#160;&#177;&#160;0.20%, and IL&#8208;1&#946; 1.39&#160;&#177;&#160;0.36% and 0.63&#160;&#177;&#160;0.07%, respectively). This similarity was also observed in unstimulated conditions. These experiments showed that replicate measurements of the same sample varied less than those between healthy donors, suggesting that donor variation reflects biological differences rather than measurement error. The undefined SAID sample (measured once due to low availability), was nonsignificantly different in cytokine&#8208;SCs frequencies compared with healthy controls in both conditions.</p><p>Second, it was further possible to identify the co&#8208;secreting behavior of various subpopulations (Figure&#160;<xref rid="eji70047-fig-0001" ref-type="fig">1D</xref>). Here, IL&#8208;6+TNF&#8208;&#945; refers to IL&#8208;6 SCs that also co&#8208;secrete TNF&#8208;&#945;, whereas TNF&#8208;&#945;+IL&#8208;6 would consequently refer to TNF&#8208;&#945; SCs that also co&#8208;secrete IL&#8208;6. In healthy donors and after 6&#160;h of stimulation with LPS, IL&#8208;6 was mostly secreted by itself (49.1&#160;&#177;&#160;8.1%) or co&#8208;secreted with +TNF&#8208;&#945; (31.7&#160;&#177;&#160;6.6%), with little co&#8208;secretion with +IL&#8208;1&#946; (10.5&#160;&#177;&#160;3.7%) or with both (+IL&#8208;1&#946;+TNF&#8208;&#945; 8.6&#160;&#177;&#160;3.9%). TNF&#8208;&#945;, on the other hand, was in the majority co&#8208;secreted with +IL&#8208;6 (52.2&#160;&#177;&#160;8.5%), and to a lesser extent, secreted alone (27.5&#160;&#177;&#160;9.3%) or in combination with +IL&#8208;1&#946; (6.9 &#177; 3.1%) or with +IL&#8208;6+IL&#8208;1&#946; (14.6&#160;&#177;&#160;5.7%). Lastly, IL&#8208;1&#946; was primarily secreted by itself (66.5&#160;&#177;&#160;9.1%), to a lesser degree co&#8208;secreted with +IL&#8208;6 (15.3&#160;&#177;&#160;5.6%), +TNF&#8208;&#945; (6.5 &#177; 3.9%) or both (12.7&#160;&#177;&#160;5.2%). Without stimulation, the observed polyfunctionalities were largely decreased in healthy donors, as expected, as the three cytokines were primarily secreted by themselves.</p><p>Interestingly, already unstimulated PBMCs of the undefined SAID patient showed an increase in co&#8208;secretion with +TNF&#8208;&#945;, of IL&#8208;6 and IL&#8208;1&#946; SCs. In this sample, IL&#8208;6 was secreted by itself in only 41.9% of all IL&#8208;6&#8208;SCs (compared with 75.5&#160;&#177;&#160;10.7% in healthy donors, <italic toggle="yes">p</italic>&#160;=&#160;0.07). The co&#8208;secretion with +TNF&#8208;&#945; corresponded to 54.8% of all IL&#8208;6&#8208;SCs, which was a clear increase compared with healthy controls (21.9&#160;&#177;&#160;9.6%, <italic toggle="yes">p</italic>&#160;=&#160;0.046). Additionally, IL&#8208;1&#946; single&#8208;secretion was observed in only to 66% of all cells secreting IL&#8208;1&#946; (91.7&#160;&#177;&#160;7.7% in healthy controls, <italic toggle="yes">p</italic>&#160;=&#160;0.059), and the co&#8208;secretion with +TNF&#8208;&#945; was increased to 16% compared with the control group (1.2&#160;&#177;&#160;2.3%, <italic toggle="yes">p</italic>&#160;=&#160;0.001), and TRAPS samples (0&#160;&#177;&#160;0% in both cases, <italic toggle="yes">p</italic>&#160;=&#160;0.0043). Interestingly, these differences disappeared after stimulation (Figure&#160;<xref rid="eji70047-fig-0001" ref-type="fig">1D</xref>, first row). Hence, in the absence of stimulus, the immune cells of the undefined SAID patient displayed an increase in the prevalence of co&#8208;secreted TNF&#8208;&#945; compared with the other groups.</p><p>Next, we further focused on the secreted amounts and rates, focusing on the 6&#160;h time point. Secreted concentrations and secretion rates (SRs) varied with polyfunctionality in LPS&#8208;stimulated cells but were similar between healthy and SAIDs patients (Figure&#160;<xref rid="eji70047-fig-0002" ref-type="fig">2</xref>). Specifically, the secretion of IL&#8208;6 displayed differences according to the co&#8208;secretion groups (Figure&#160;<xref rid="eji70047-fig-0002" ref-type="fig">2A</xref>). When IL&#8208;6 was co&#8208;secreted with +TNF&#8208;&#945; or with +TNF&#8208;&#945;+IL&#8208;1&#946;, the maximum secreted concentration of IL&#8208;6 was higher compared with the other groups (IL&#8208;6 alone, or +IL&#8208;1&#946;, <italic toggle="yes">p</italic>&#160;&lt;&#160;0.0001). These higher concentrations were due to increased SRs (Figure&#160;<xref rid="eji70047-fig-0002" ref-type="fig">2B</xref>), where cells secreting IL&#8208;6+TNF&#8208;&#945; or IL&#8208;6+TNF&#8208;&#945;+IL&#8208;1&#946; had a 5&#215; higher median IL&#8208;6 SR (<italic toggle="yes">p</italic>&#160;&lt;&#160;0.0001). TNF&#8208;&#945; secretion was similar across co&#8208;secreting subpopulations. IL&#8208;1&#946; also displayed a differential secretion concentration and SR in +IL&#8208;6 or +TNF&#8208;&#945; SCs. However, in this case, the maximal IL&#8208;1&#946; concentration as well as SR were increased in +IL&#8208;6, +TNF&#8208;&#945;, and +IL&#8208;6+TNF&#8208;&#945; SCs, compared with cells secreting only IL&#8208;1&#946;. Regarding the unstimulated conditions, the cells were mostly secreting single cytokines (Figure&#160;<xref rid="eji70047-fig-0002" ref-type="fig">2A</xref>). In summary, secreted concentrations and SRs at the single&#8208;cell level showed no major differences between healthy and SAIDs patient samples, with all three patients falling largely within the normal range across categories.</p><fig position="float" fig-type="FIGURE" id="eji70047-fig-0002" orientation="portrait"><label>FIGURE 2</label><caption><p>Median maximal secreted concentration (A) and SR (B) of IL&#8208;6, TNF&#8208;&#945;, and IL&#8208;1&#946; after 6&#160;h of LPS stimulation or unstimulated controls. Lines indicate median&#160;&#177;&#160;IQR (95%). Same samples as Figure&#160;<xref rid="eji70047-fig-0001" ref-type="fig">1</xref>, <italic toggle="yes">n</italic>&#160;&lt;&#160;5 SCs were excluded. Group differences were analyzed by Kruskal&#8211;Wallis with Dunn's post hoc test. Significance: *<italic toggle="yes">p&#160;</italic>&lt;&#160;0.05, **<italic toggle="yes">p&#160;</italic>&lt;&#160;0.01, ***<italic toggle="yes">p&#160;</italic>&lt;&#160;0.001.</p></caption><graphic position="anchor" id="jats-graphic-5" orientation="portrait" xlink:href="EJI-55-e70047-g003.jpg"/></fig><p>We observed cytokine&#8208;specific differences in the dynamics of secretion, which did not differ between patients and healthy individuals (Figure <xref rid="eji70047-supinfo-0001" ref-type="">S5</xref>). Even when tested at a different time point, the secretion dynamics showed no significant differences between patients and controls (Figures <xref rid="eji70047-supinfo-0001" ref-type="">S2</xref>&#8211;<xref rid="eji70047-supinfo-0001" ref-type="">S4</xref>, <xref rid="eji70047-supinfo-0001" ref-type="">S6</xref>). Bulk cytokine levels measured by ELISA confirmed these findings (Figure <xref rid="eji70047-supinfo-0001" ref-type="">S7</xref>).</p><p>As a complement to genetic testing, we propose a method that directly measures cytokine secretion from individual immune cells, capturing both mono&#8208; and polyfunctionality alongside other cellular features. By layering functional data on top of genetic information, this method may help reveal the downstream effects of mutations and could be especially valuable for patients in whom no disease&#8208;causing mutation is identified. In this study, we observed increased cytokine TNF&#8208;&#945; co&#8208;secretion in resting immune cells from a patient with an undefined SAID, suggesting a distinct activation&#8208;like phenotype not present in PBMCs from healthy controls or two TRAPS patients, nor reflected in serum measurements. Consequently, single&#8208;cell cytokine profiling might reveal the consequences of mutations with unique immune signatures in SAIDs missed by genetic testing, but faces challenges from disease variability, potentially requiring adaptation. Therefore, different SAIDs may require tailored cytokine panels, making broad screening impractical, but might further enable personalized therapy after diagnosis thus, larger and more diverse studies are needed to evaluate their clinical value.</p><sec sec-type="COI-statement" id="eji70047-sec-0030"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></sec><sec sec-type="peer-review" id="eji70047-sec-0060"><title>Peer Review</title><p>The peer review history for this article is available at <ext-link xlink:href="https://publons.com/publon/10.1002/eji.70047" ext-link-type="uri">https://publons.com/publon/10.1002/eji.70047</ext-link>.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="eji70047-supinfo-0001" position="float" content-type="local-data" orientation="portrait"/><supplementary-material id="eji70047-supitem-0001" position="float" content-type="local-data" orientation="portrait"><caption><p>
<bold>Supporting file 1</bold>: eji70047&#8208;sup&#8208;0001&#8208;SuppMat.pdf</p></caption><media xlink:href="EJI-55-e70047-s001.pdf" position="float" orientation="portrait"/></supplementary-material></sec></body><back><ack id="eji70047-sec-0020"><title>Acknowledgments</title><p>This project was supported by grant #2021&#8208;349 of the Strategic Focus Area &#8220;Personalized Health and Related Technologies (PHRT)&#8221; of the ETH Domain, and we thank the Statistical Consulting service for their advice. We gratefully acknowledge the patients and healthy volunteers for their participation.</p></ack><sec sec-type="data-availability" id="eji70047-sec-0050"><title>Data Availability Statement</title><p>The data that support the findings of this study are available on request from the corresponding author.</p></sec><ref-list id="eji70047-bibl-0001"><title>References</title><ref id="eji70047-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="eji70047-cite-0001"><string-name name-style="western"><given-names>S.</given-names><surname>Ozen</surname></string-name> and <string-name name-style="western"><given-names>I.</given-names><surname>Aksentijevich</surname></string-name>, &#8220;<article-title>The Past 25 Years in Paediatric Rheumatology: Insights From Monogenic Diseases</article-title>,&#8221; <source>Nature Reviews Rheumatology</source><volume>20</volume> (<year>2024</year>): <fpage>585</fpage>&#8211;<lpage>593</lpage>.<pub-id pub-id-type="pmid">39112602</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41584-024-01145-1</pub-id></mixed-citation></ref><ref id="eji70047-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="eji70047-cite-0002"><string-name name-style="western"><given-names>I.</given-names><surname>Aksentijevich</surname></string-name> and <string-name name-style="western"><given-names>O.</given-names><surname>Schnappauf</surname></string-name>, &#8220;<article-title>Molecular Mechanisms of Phenotypic Variability in Monogenic Autoinflammatory Diseases</article-title>,&#8221; <source>Nature Reviews Rheumatology</source><volume>17</volume> (<year>2021</year>): <fpage>405</fpage>&#8211;<lpage>425</lpage>.<pub-id pub-id-type="pmid">34035534</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41584-021-00614-1</pub-id></mixed-citation></ref><ref id="eji70047-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="eji70047-cite-0003"><string-name name-style="western"><given-names>A.</given-names><surname>Chaaban</surname></string-name>, <string-name name-style="western"><given-names>H.</given-names><surname>Yassine</surname></string-name>, <string-name name-style="western"><given-names>R.</given-names><surname>Hammoud</surname></string-name>, <string-name name-style="western"><given-names>R.</given-names><surname>Kanaan</surname></string-name>, <string-name name-style="western"><given-names>L.</given-names><surname>Karam</surname></string-name>, and <string-name name-style="western"><given-names>J.</given-names><surname>Ibrahim</surname></string-name>, &#8220;<article-title>A Narrative Review on the Role of Cytokines in the Pathogenesis and Treatment of Familial Mediterranean Fever: An Emphasis on Pediatric Cases</article-title>,&#8221; <source>Frontiers in Pediatrics</source><volume>12</volume> (<year>2024</year>): <elocation-id>1421353</elocation-id>.<pub-id pub-id-type="pmid">39132307</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fped.2024.1421353</pub-id><pub-id pub-id-type="pmcid">PMC11310175</pub-id></mixed-citation></ref><ref id="eji70047-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="eji70047-cite-0004"><string-name name-style="western"><given-names>N. M</given-names><surname>Ter Haar</surname></string-name>, <string-name name-style="western"><given-names>C.</given-names><surname>Eijkelboom</surname></string-name>, <string-name name-style="western"><given-names>L.</given-names><surname>Cantarini</surname></string-name>, et&#160;al., &#8220;<article-title>Clinical Characteristics and Genetic Analyses of 187 Patients With Undefined Autoinflammatory Diseases</article-title>,&#8221; <source>Annals of the Rheumatic Diseases</source><volume>78</volume> (<year>2019</year>): <fpage>1405</fpage>&#8211;<lpage>1411</lpage>.<pub-id pub-id-type="pmid">31278138</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/annrheumdis-2018-214472</pub-id></mixed-citation></ref><ref id="eji70047-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="eji70047-cite-0005"><string-name name-style="western"><given-names>M. F</given-names><surname>McDermott</surname></string-name>, <string-name name-style="western"><given-names>I.</given-names><surname>Aksentijevich</surname></string-name>, <string-name name-style="western"><given-names>J.</given-names><surname>Galon</surname></string-name>, et&#160;al., &#8220;<article-title>Germline Mutations in the Extracellular Domains of the 55 kDa TNF Receptor, TNFR1, Define a Family of Dominantly Inherited Autoinflammatory Syndromes</article-title>,&#8221; <source>Cell</source><volume>97</volume> (<year>1999</year>): <fpage>133</fpage>&#8211;<lpage>144</lpage>.<pub-id pub-id-type="pmid">10199409</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0092-8674(00)80721-7</pub-id></mixed-citation></ref><ref id="eji70047-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="eji70047-cite-0006"><string-name name-style="western"><given-names>J.</given-names><surname>Krainer</surname></string-name>, <string-name name-style="western"><given-names>S.</given-names><surname>Siebenhandl</surname></string-name>, and <string-name name-style="western"><given-names>A.</given-names><surname>Weinh&#228;usel</surname></string-name>, &#8220;<article-title>Systemic Autoinflammatory Diseases</article-title>,&#8221; <source>Journal of Autoimmunity</source><volume>109</volume> (<year>2020</year>): <elocation-id>102421</elocation-id>.<pub-id pub-id-type="pmid">32019685</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jaut.2020.102421</pub-id><pub-id pub-id-type="pmcid">PMC7610735</pub-id></mixed-citation></ref><ref id="eji70047-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="eji70047-cite-0007"><string-name name-style="western"><given-names>A.</given-names><surname>Soriano</surname></string-name>, <string-name name-style="western"><given-names>M.</given-names><surname>Soriano</surname></string-name>, <string-name name-style="western"><given-names>G.</given-names><surname>Espinosa</surname></string-name>, et&#160;al., &#8220;<article-title>Current Therapeutic Options for the Main Monogenic Autoinflammatory Diseases and PFAPA Syndrome: Evidence&#8208;Based Approach and Proposal of a Practical Guide</article-title>,&#8221; <source>Frontiers in immunology</source><volume>11</volume> (<year>2020</year>): <fpage>865</fpage>.<pub-id pub-id-type="pmid">32655539</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2020.00865</pub-id><pub-id pub-id-type="pmcid">PMC7325944</pub-id></mixed-citation></ref><ref id="eji70047-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="eji70047-cite-0008"><string-name name-style="western"><given-names>K.</given-names><surname>Portmann</surname></string-name>, <string-name name-style="western"><given-names>A.</given-names><surname>Linder</surname></string-name>, and <string-name name-style="western"><given-names>K.</given-names><surname>Eyer</surname></string-name>, &#8220;<article-title>Stimulation&#8208;induced Cytokine Polyfunctionality as a Dynamic Concept</article-title>,&#8221; <source>Elife</source><volume>12</volume> (<year>2024</year>): <elocation-id>RP89781</elocation-id>.<pub-id pub-id-type="pmid">39018359</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7554/eLife.89781</pub-id><pub-id pub-id-type="pmcid">PMC11254380</pub-id></mixed-citation></ref><ref id="eji70047-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="eji70047-cite-0009"><string-name name-style="western"><given-names>K.</given-names><surname>Portmann</surname></string-name>, <string-name name-style="western"><given-names>A.</given-names><surname>Linder</surname></string-name>, <string-name name-style="western"><given-names>N.</given-names><surname>Oelgarth</surname></string-name>, and <string-name name-style="western"><given-names>K.</given-names><surname>Eyer</surname></string-name>, &#8220;<article-title>Single&#8208;cell Deep Phenotyping of Cytokine Release Unmasks Stimulation&#8208;Specific Biological Signatures and Distinct Secretion Dynamics</article-title>,&#8221; <source>Cell Reports Methods</source><volume>3</volume> (<year>2023</year>): <elocation-id>100502</elocation-id>.<pub-id pub-id-type="pmid">37533643</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.crmeth.2023.100502</pub-id><pub-id pub-id-type="pmcid">PMC10391336</pub-id></mixed-citation></ref><ref id="eji70047-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="eji70047-cite-0010"><string-name name-style="western"><given-names>A.</given-names><surname>Linder</surname></string-name>, <string-name name-style="western"><given-names>K.</given-names><surname>Portmann</surname></string-name>, and <string-name name-style="western"><given-names>K.</given-names><surname>Eyer</surname></string-name>, &#8220;<article-title>The Impact of Cryopreservation on Cytokine Secretion and Polyfunctionality in human PBMCs: A Comparative Study</article-title>,&#8221; <source>Frontiers in Immunology</source><volume>15</volume> (<year>2024</year>): <elocation-id>1478311</elocation-id>.<pub-id pub-id-type="pmid">39434875</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2024.1478311</pub-id><pub-id pub-id-type="pmcid">PMC11491348</pub-id></mixed-citation></ref></ref-list></back></article>
        
    </metadata>
</record>
    </GetRecord>

</OAI-PMH>